• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

NAKAGAWA TOHRU  中川 徹

ORCIDConnect your ORCID iD *help
… Alternative Names

NAKAGAWA Tohru  中川 徹

Less
Researcher Number 40591730
Other IDs
Affiliation (Current) 2025: 帝京大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2025: 帝京大学, 医学部, 教授
2017 – 2023: 帝京大学, 医学部, 教授
2013 – 2016: 東京大学, 医学部附属病院, 講師
Review Section/Research Field
Principal Investigator
Urology
Except Principal Investigator
Basic Section 56030:Urology-related / Urology / Sections That Are Subject to Joint Review: Basic Section90130:Medical systems-related , Basic Section90140:Medical technology assessment-related / Basic Section 90140:Medical technology assessment-related / Basic Section 90130:Medical systems-related / Basic Section 47060:Clinical pharmacy-related / Tumor therapeutics
Keywords
Principal Investigator
ネオアンチゲン / 癌精巣抗原 / Tim-3 / PD-1 / 免疫チェックポイント阻害剤 / ガンマデルタT細胞 / 免疫療法 / NKG2D / γδT細胞 / CIBERSORT / 次世代シーケンサー / 腫瘍免疫 / 尿路上皮癌 … More
Except Principal Investigator
… More 免疫療法 / 腎細胞癌 / 超音波 / 膀胱癌 / マイクロバブル / 薬剤服用歴 / イムノグラム / 免疫チェックポイント阻害薬 / ペムブロリズマブ / 尿路上皮癌 / ESS2 / RORγ / ESS2 / RORγ / 前立腺癌 / IFNg / HLA-A2トランスジェニックマウス / MHCクラスI結合予測 / HLA-A2 トランスジェニックマウス / IFN-gamma / トランスジェニックマウス / HLA-A2 / T細胞 / MHC class I 結合予測 / ネオエピトープ / 腎がん / MHC結合予測アルゴリズム / ネオ抗原 / 遺伝子変異 / 腎癌 / クロマチン異常 / 癌進展 / クロマチン制御関連遺伝子 / 癌の進展 / クロマチン制御遺伝子 / 分子標的薬 / インターフェロン / 樹状細胞療法 Less
  • Research Projects

    (8 results)
  • Research Products

    (19 results)
  • Co-Researchers

    (16 People)
  •  薬剤性認知症回避を目指した抗コリン薬の新規リスク指標開発

    • Principal Investigator
      黄倉 崇
    • Project Period (FY)
      2025 – 2028
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Teikyo University
  •  Development of a Novel Therapy for Invasive Bladder Cancer Using Ultrasound-Responsive Microbubbles

    • Principal Investigator
      川合 剛人
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 90130:Medical systems-related
      Basic Section 90140:Medical technology assessment-related
      Sections That Are Subject to Joint Review: Basic Section90130:Medical systems-related , Basic Section90140:Medical technology assessment-related
    • Research Institution
      International University of Health and Welfare
  •  Tailor-made immunotherapy strategy for urothelial cancer using immunogram

    • Principal Investigator
      Kawai Taketo
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Teikyo University
  •  Development of immunotherapy for castration resistant prostate cancer targeting a novel cofactor of RORgamma

    • Principal Investigator
      Takahashi Sayuri
    • Project Period (FY)
      2018 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      The University of Tokyo
      Teikyo University
  •  Development of cancer immunotherapy targeting mutation-derived neoantigens

    • Principal Investigator
      MATSUSHITA Hirokazu
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Aichi Cancer Center Research Institute
      The University of Tokyo
  •  Analysis of intra-tumor immune response toward development of autologous gamma-delta T-cell transfer therapy in patients with advanced urothelial carcinomaPrincipal Investigator

    • Principal Investigator
      Nakagawa Tohru
    • Project Period (FY)
      2015 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Teikyo University
      The University of Tokyo
  •  Role of the chromatin regulating genes in the progression of renal cell carcinoma

    • Principal Investigator
      Kume Haruki
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      The University of Tokyo
  •  DC-based vaccination combined with interferon for metastatic renal cell carcinoma

    • Principal Investigator
      ENOMOTO Yutaka
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      The University of Tokyo

All 2023 2022 2021 2019 2018 2017 2016 2015

All Journal Article Presentation

  • [Journal Article] Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab2023

    • Author(s)
      Taguchi S, Kawai T, Buti S, Bersanelli M, Uemura Y, Kishitani K, Miyakawa J, Sugimoto K, Nakamura Y, Niimi F, Kaneko T, Kamei J, Obinata D, Yamaguchi K, Kakutani S, Kanazawa K, Sugihara Y, Tokunaga M, Akiyama Y, Yamada Y, Sato Y, Yamada D, Enomoto Y, Nishimatsu H, Fujimura T, Fukuhara H, Nakagawa T, Takahashi S, Kume H
    • Journal Title

      Immunotherapy

      Volume: 15 Issue: 11 Pages: 827

    • DOI

      10.2217/imt-2023-0028

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K09368, KAKENHI-PROJECT-23K15781
  • [Journal Article] Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: A multicenter retrospective study using time-dependent analysis2022

    • Author(s)
      Kawai Taketo、Taguchi Satoru、Nakagawa Tohru、Kamei Jun、Nakamura Yu、Obinata Daisuke、Yamaguchi Kenya、Kaneko Tomoyuki、Kakutani Shigenori、Tokunaga Mayuko、Uemura Yukari、Sato Yusuke、Enomoto Yutaka、Nishimatsu Hiroaki、Fujimura Tetsuya、Fukuhara Hiroshi、Takahashi Satoru、Kume Haruki
    • Journal Title

      Journal for ImmunoTherapy of Cancer

      Volume: 10 Issue: 2 Pages: e003965-e003965

    • DOI

      10.1136/jitc-2021-003965

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K09368, KAKENHI-PROJECT-19K09720
  • [Journal Article] Transcriptional coregulator Ess2 controls survival of post-thymic CD4+ T cells through the Myc and IL-7 signaling pathways2022

    • Author(s)
      Takada I‡, Hidano S‡, Takahashi S‡, Ogawa H, Tsuchiya M, Yokoyama A, Sato S, Ochi H, Nakagawa T, Kobayashi T, Nakagawa S, Makishima M
    • Journal Title

      Journal of Biological Chemistry

      Volume: 298 Pages: 102342-102342

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K09162
  • [Journal Article] Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study2021

    • Author(s)
      Taguchi Satoru、Kawai Taketo、Nakagawa Tohru、Nakamura Yu、Kamei Jun、Obinata Daisuke、Yamaguchi Kenya、Kaneko Tomoyuki、Kakutani Shigenori、Tokunaga Mayuko、Uemura Yukari、Sato Yusuke、Fujimura Tetsuya、Fukuhara Hiroshi、Enomoto Yutaka、Nishimatsu Hiroaki、Takahashi Satoru、Kume Haruki
    • Journal Title

      Scientific Reports

      Volume: 11 Issue: 1 Pages: 15623-15623

    • DOI

      10.1038/s41598-021-95061-z

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K09368, KAKENHI-PROJECT-19K09720
  • [Journal Article] Clinical significance of random bladder biopsy in primary T1 bladder cancer2018

    • Author(s)
      Otsuka Masafumi、Taguchi Satoru、Nakagawa Tohru、Morikawa Teppei、Maekawa Shigekatsu、Miyakawa Jimpei、Matsumoto Akihiko、Miyazaki Hideyo、Fujimura Tetsuya、Fukuhara Hiroshi、Kume Haruki、Igawa Yasuhiko、Homma Yukio
    • Journal Title

      Molecular and Clinical Oncology

      Volume: 8 Pages: 665-670

    • DOI

      10.3892/mco.2018.1587

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10577, KAKENHI-PROJECT-16K10996
  • [Journal Article] Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer2018

    • Author(s)
      4.Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi, S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y,Homma Y.
    • Journal Title

      World J Urol

      Volume: 36 Issue: 2 Pages: 249

    • DOI

      10.1007/s00345-017-2141-2

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10577, KAKENHI-PROJECT-16K10996
  • [Journal Article] Loss of Stromal Antigen 2 (STAG2) Expression in Upper Urinary Tract Carcinoma: Differential Prognostic Effect According to the Ki-67 Proliferating Index2017

    • Author(s)
      1.Miyakawa J, Morikawa T, Miyama Y, Nakagawa T, Kawai T, Homma Y, Fukayama M.
    • Journal Title

      Ann Surg Oncol

      Volume: 24 Issue: 13 Pages: 4059

    • DOI

      10.1245/s10434-017-6097-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10577, KAKENHI-PROJECT-17K15635
  • [Journal Article] Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study2017

    • Author(s)
      2.Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y, Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    • Journal Title

      World J Urol

      Volume: 35 Issue: 10 Pages: 1569

    • DOI

      10.1007/s00345-017-2032-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10577
  • [Journal Article] Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder2017

    • Author(s)
      Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A, Yoshida K, Kawai T, Nagata M, Yamada D, Komemushi Y, Suzuki M, Enomoto Y, Nishimatsu H, Ishikawa A, Nagase Y, Kondo Y, Tanaka Y, Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y
    • Journal Title

      Urol Oncol

      Volume: 35 Issue: 7 Pages: 457.e15-457.e21

    • DOI

      10.1016/j.urolonc.2016.12.010

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10577
  • [Journal Article] Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?2017

    • Author(s)
      3.Nakagawa T, Taguchi S, Kanatani A, Kawai T, Ikeda M, Urakami S, Matsumoto A, Komemushi Y, Miyakawa J, Yamada D, Suzuki M, Enomoto Y, Nishimatsu H, Kondo Y, Nagase Y, Hirano Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y
    • Journal Title

      Ann Surg Oncol.

      Volume: 24 Issue: 9 Pages: 2794

    • DOI

      10.1245/s10434-017-5970-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10577
  • [Journal Article] Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma2016

    • Author(s)
      Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K
    • Journal Title

      Cancer Immunol Res.

      Volume: 4 Pages: 463-71

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K07162
  • [Journal Article] Neoantigen load, antigen presentation machinery, and immune signatures determine prognosis in clear cell renal cell carcinoma2016

    • Author(s)
      Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K.
    • Journal Title

      Cancer Immunol Res.

      Volume: 4 Issue: 5 Pages: 463

    • DOI

      10.1158/2326-6066.cir-15-0225

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K10577, KAKENHI-PROJECT-15H04942
  • [Journal Article] Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.2016

    • Author(s)
      Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K.
    • Journal Title

      Cancer Immunol Res

      Volume: 未

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26462402
  • [Journal Article] MAGE-A expression, immune microenvironment, and prognosis in upper urinary tract carcinoma2016

    • Author(s)
      Makise N, Morikawa T, Nakagawa T, Ichimura T, Kawai T, Matsushita H, Kakimi K, Kume H, Homma Y, Fukayama M.
    • Journal Title

      Human Pathology

      Volume: 50 Pages: 62

    • DOI

      10.1016/j.humpath.2015.11.007

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-15K10577, KAKENHI-PROJECT-25460412
  • [Presentation] 新規RORγ転写共役因子ESS2遺伝子の同定および前立腺癌増悪のメカニズムの解明2019

    • Author(s)
      高橋 さゆり,久米 春喜,中川 徹
    • Organizer
      第69回日本泌尿器科学会中部総会
    • Data Source
      KAKENHI-PROJECT-18K09162
  • [Presentation] 核内受容体RORγの新規転写共役因子ESS2は染色体凝縮・分裂を制御し前立腺癌を増悪させる2019

    • Author(s)
      高橋 さゆり,山田幸央,久米 春喜,中川 徹
    • Organizer
      日本泌尿器腫瘍学会第5回学術集会
    • Data Source
      KAKENHI-PROJECT-18K09162
  • [Presentation] 進行性膀胱癌に対する膀胱全摘術後の補助化学療法の有用性の検討:多施設共同研究.2018

    • Author(s)
      1.金谷淳志、松本明彦、川合剛人、池田勝臣、宮川仁平、田口慧、内藤晶裕、大塚真史、中西泰一、東剛司、鈴木基文、古賀文隆、近藤靖司、岡根谷利一、田中良典、久米春喜、中川徹.
    • Organizer
      第106回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-15K10577
  • [Presentation] 転移性腎細胞癌に対するスニチニブ併用樹状細胞療法2017

    • Author(s)
      1.中川徹、松下博和、垣見和宏、松本明彦、宮嵜英世、藤村哲也、福原浩、榎本裕、久米春喜、本間之夫.
    • Organizer
      第105回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-15K10577
  • [Presentation] Expression of candidate neoantigens in ccRCC patients and its implication on prognosis2015

    • Author(s)
      Hirokazu Matsushita, Manami Miyai, Yusuke Sato, Tohru Nakagawa, Haruki Kume, Seishi Ogawa, Yukio Homma, Kazuhiro Kakimi
    • Organizer
      第19回日本がん免疫学会総会(ICCIM2015)
    • Place of Presentation
      伊藤国際学術研究センター(東京都文京区)
    • Year and Date
      2015-07-09
    • Data Source
      KAKENHI-PROJECT-15K10577
  • 1.  KAKIMI Kazuhiro (80273358)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 3 results
  • 2.  Kawai Taketo (60343133)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 0 results
  • 3.  Kume Haruki (10272577)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 6 results
  • 4.  MATSUSHITA Hirokazu (80597782)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 3 results
  • 5.  山田 大介 (00623696)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 6.  ENOMOTO Yutaka (20280927)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  Takahashi Sayuri (40313217)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 8.  永田 政義 (00323668)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  東 剛司 (50719854)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 10.  小林 隆志 (30380520)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 11.  佐藤 悠佑 (20372378)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 12.  黄倉 崇 (80326123)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 13.  田中 紫茉子 (10559925)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 14.  中谷 絵理子 (90803916)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 15.  宮田 敏 (60360343)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 16.  丸山 一雄 (30130040)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi